Search Results

63 articles with title/keywords/abstract containing Hsp90 Drugs

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Display per page 

Content loaded within last 14 days Ansamycin Inhibitors of Hsp90: Nature's Prototype for Anti-Chaperone Therapy

Authors: Porter, James R.; Ge, Jie; Lee, John; Normant, Emmanuel; West, Kip

Source: Current Topics in Medicinal Chemistry, Volume 9, Number 15, November 2009 , pp. 1386-1418(33)

Publisher: Bentham Science Publishers

Content loaded within last 14 days Purine-Scaffold Hsp90 Inhibitors

Authors: Taldone, Tony; Chiosis, Gabriela

Source: Current Topics in Medicinal Chemistry, Volume 9, Number 15, November 2009 , pp. 1436-1446(11)

Publisher: Bentham Science Publishers

Content loaded within last 14 days Alternate Strategies of Hsp90 Modulation for the Treatment of Cancer and Other Diseases

Authors: Brandt, Gary E.L.; Blagg, Brian S.J.

Source: Current Topics in Medicinal Chemistry, Volume 9, Number 15, November 2009 , pp. 1447-1461(15)

Publisher: Bentham Science Publishers

Content loaded within last 14 days Update on Hsp90 Inhibitors in Clinical Trial

Authors: Kim, Y. S.; Alarcon, S. V.; Lee, S.; Lee, M.-J.; Giaccone, G.; Neckers, L.; Trepel, J. B.

Source: Current Topics in Medicinal Chemistry, Volume 9, Number 15, November 2009 , pp. 1479-1492(14)

Publisher: Bentham Science Publishers

Anti-myeloma activity of the novel 2-aminothienopyrimidine Hsp90 inhibitor NVP-BEP800

Authors: Stühmer, Thorsten; Chatterjee, Manik; Grella, Evelyn; Seggewiss, Ruth; Langer, Christian; Müller, Sabine; Schoepfer, Joseph; Garcia-Echeverria, Carlos; Quadt, Cornelia; Jensen, Michael R.; Einsele, Hermann; Bargou, Ralf C.

Source: British Journal of Haematology, Volume 147, Number 3, November 2009 , pp. 319-327(9)

Publisher: Blackwell Publishing

Pathogenesis-targeting therapeutics for spinal and bulbar muscular atrophy (SBMA)

Authors: Suzuki, Keisuke; Kastuno, Masahisa; Banno, Haruhiko; Sobue, Gen

Source: Neuropathology, Volume 29, Number 4, August 2009 , pp. 509-516(8)

Publisher: Blackwell Publishing

HSP90 Inhibitors: Multi-Targeted Antitumor Effects and Novel Combinatorial Therapeutic Approaches in Cancer Therapy

Authors: Hwang, Misun; Moretti, Luigi; Lu, Bo

Source: Current Medicinal Chemistry, Volume 16, Number 24, August 2009 , pp. 3081-3092(12)

Publisher: Bentham Science Publishers

Impact of heat-shock protein 90 on cancer metastasis

Authors: Tsutsumi, Shinji; Beebe, Kristin; Neckers, Len

Source: Future Oncology, Volume 5, Number 5, June 2009 , pp. 679-688(10)

Publisher: Future Medicine

Potent Triazolothione Inhibitor of Heat-Shock Protein-90

Authors: Feldman, Richard I.; Mintzer, Bob; Zhu, Daguang; Wu, James M.; Biroc, Sandra L.; Yuan, Shendong; Emayan, Kumar; Chang, Zheng; Chen, Deborah; Arnaiz, Damian O.; Bryant, Judi; Ge, Xue Snow; Whitlow, Marc; Adler, Marc; Polokoff, Mark A.; Li, Wei-Wei; Ferrer, Mike; Sato, Takashi; Gu, Jian-Ming; Shen, Jun; Tseng, Jih-Lie; Dinter, Harald; Buckman, Brad

Source: Chemical Biology & Drug Design, Volume 74, Number 1, July 2009 , pp. 43-50(8)

Publisher: Blackwell Publishing

Human 90 kDa Heat Shock Protein Hsp90 as a Target for Cancer Therapeutics

Authors: Gava, Lisandra M.; Ramos, Carlos H.I.

Source: Current Chemical Biology, Volume 3, Number 1, January 2009 , pp. 10-21(12)

Publisher: Bentham Science Publishers

Novobiocin and Additional Inhibitors of the Hsp90 C-Terminal Nucleotide- binding Pocket

Authors: Donnelly, Alison; Blagg, Brian S.J.

Source: Current Medicinal Chemistry, Volume 15, Number 26, November 2008 , pp. 2702-2717(16)

Publisher: Bentham Science Publishers

An in vitro and in vivo study of the combination of the heat shock protein inhibitor 17-allylamino-17-demethoxygeldanamycin and carboplatin in human ovarian cancer models

Authors: Banerji, Udai; Sain, Nivedita; Sharp, Swee; Valenti, Melanie; Asad, Yasmin; Ruddle, Ruth; Raynaud, Florence; Walton, Michael; Eccles, Suzanne; Judson, Ian; Jackman, Ann; Workman, Paul

Source: Cancer Chemotherapy and Pharmacology, Volume 62, Number 5, October 2008 , pp. 769-778(10)

Publisher: Springer

Analysis of gene and protein expression of cytochrome P450 and stress-associated molecules in rat liver after spaceflight

Authors: Baba, Taisuke; Nishimura, Masuhiro; Kuwahara, Yoshikazu; Ueda, Nobuhiko; Naitoh, Shinsaku; Kume, Makoto; Yamamoto, Yuzo; Fujita, Jun; Funae, Yoshihiko; Fukumoto, Manabu

Source: Pathology International, Volume 58, Number 9, September 2008 , pp. 589-595(7)

Publisher: Blackwell Publishing

Oncologic, Endocrine & Metabolic Emerging drugs in B-cell non-Hodgkin's lymphoma

Authors: Kassam, Shireen; Montoto, Silvia

Source: Expert Opinion on Emerging Drugs, Volume 13, Number 2, June 2008 , pp. 323-343(21)

Publisher: Informa Healthcare

Membranes: a meeting point for lipids, proteins and therapies

Authors: Escribá, Pablo V.; González-Ros, José M.; Goñi, Félix M.; Kinnunen, Paavo K. J.; Vigh, Lászlo; Sánchez-Magraner, Lissete; Fernández, Asia M.; Busquets, Xavier; Horváth, Ibolya; Barceló-Coblijn, Gwendolyn

Source: Journal of Cellular and Molecular Medicine, Volume 12, Number 3, June 2008 , pp. 829-875(47)

Publisher: Blackwell Publishing

HER-2 Positive Breast Cancer: What Else Beyond Trastuzumab-Based Therapy?

Authors: Widakowich, Christian; Dinh, Phuong; Azambuja, Evandro d.; Awada, Ahmad; Piccart-Gebhart, Martine

Source: Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry, Volume 8, Number 5, June 2008 , pp. 488-496(9)

Publisher: Bentham Science Publishers

Structural Models and Binding Site Prediction of the C-terminal Domain of Human Hsp90: A New Target for Anticancer Drugs

Authors: Sgobba, Miriam; Degliesposti, Gianluca; Ferrari, Anna Maria; Rastelli, Giulio

Source: Chemical Biology & Drug Design, Volume 71, Number 5, May 2008 , pp. 420-433(14)

Publisher: Blackwell Publishing

Heat shock protein 90: The cancer chaperone

Author: Neckers, Len

Source: Journal of Biosciences, Volume 32, Number 3, April 2007 , pp. 517-530(14)

Publisher: Springer

Trichosanthin down-regulated p210Bcr-Abl and enhanced imatinib-induced growth arrest in chronic myelogenous leukemia cell line K562

Authors: Zhang, Kunzhong; Xu, Jianhua; Huang, Xiuwang; Wu, Lixian; Wen, Caixia; Hu, Yingying; Su, Yu; Chen, Yuanzhong; Zhang, Zhiqiang

Source: Cancer Chemotherapy and Pharmacology, Volume 60, Number 4, September 2007 , pp. 581-587(7)

Publisher: Springer

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A